Stay updated with breaking news from 69404d10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by research analysts at Piper Sandler from $9.00 to $8.00 in a research report issued on Monday, Benzinga reports. The firm currently has a “neutral” rating on the biotechnology company’s stock. Piper Sandler’s price objective indicates a potential upside of 17.99% […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) posted its earnings results on Monday. The biotechnology company reported ($0.27) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.02, RTT News reports. Pacific Biosciences of California had a negative net margin of 182.34% and a negative return on equity of 45.64%. The […]
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) was upgraded by Cantor Fitzgerald from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Tuesday, Marketbeat reports. The brokerage presently has a $11.00 price target on the biotechnology company’s stock. Cantor Fitzgerald’s price objective would indicate a […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective trimmed by Morgan Stanley from $13.00 to $10.00 in a research note released on Tuesday, Benzinga reports. The firm currently has an equal weight rating on the biotechnology company’s stock. PACB has been the topic of several other research reports. The Goldman Sachs […]
Steel Peak Wealth Management LLC acquired a new stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) during the second quarter, according to its most recent disclosure with the SEC. The fund acquired 15,848 shares of the biotechnology company’s stock, valued at approximately $211,000. A number of other large investors have […]